Research Programs

images/research.png

Human papillomavirus (HPV)-related oropharyngeal cancer incidence and trends in India

images/research.png

Understanding the natural history of oral HPV infection: an Indian perspective

images/research.png

Biomarkers of oral cancer risk prediction

images/research.png

Aetiology of human papillomavirus infections in head and neck cancer

images/research.png

Molecular HPV tests to establish endpoints for primary prevention of cervical cancer

images/research.png

Correlates of long lasting cell-mediated immune memory response to HPV vaccination

Current Research Grants

  • 2025 2020

    Accurate and satisfactory analysis of all high risk HPV types and some of the low risks including HPV 6 and 11 antibody titers for the 2-versus 3 dose HPV vaccination clinical trial in India- Follow-up study
    International Agency for Research on Cancer [IARC]- WHO

  • 2024 2019

    Human papillomavirus (HPV)-related oropharyngeal cancer burdenand the natural history of oral HPV infections: an Indianperspective.
    Wellcome Trust (UK) India Alliance program by the Department of Biotechnology [DBT]

  • 2023 2018

    Biomarkers of oral cancer risk prediction
    Department of Biotechnology [DBT]

  • 2022 2019

    HPV genotyping for efficacy testing of generic qHPV vaccine development: Serum Institute of India study
    Serum Institute of India

Contact

Rajiv Gandhi Centre for Biotechnology (RGCB),
Thycaud Post, Poojappura,
Thiruvananthapuram - 695 014, Kerala, India
+91-471-2529400 | 2347975 | 2348753
+91-471-2348096
webmaster@rgcb.res.in

My Gov www.mygov.in Prime Ministers National Relife Fund India Gov www.india.gov.in Make In India www.makeinindia.gov.in Make In India www.iredibleindia.org Data gov in www.data.gov.in www.pib.gov.in

Last Updated on: March 04, 2024
CERT-In Certified Website